β-cell-specific gene repression: A mechanism to protect against inappropriate or maladjusted insulin secretion?

Diabetes

Volumn 61, Issue 5, 2012, Pages 969-975

  Schuit, Frans ^a   Van Lommel, Leentje ^a   Granvik, Mikaela ^a   Goyvaerts, Lotte ^a   De Faudeur, Geoffroy ^a   Schraenen, Anica ^a   Lemaire, Katleen ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUCOKINASE; GLUCOSE; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 1; ORNITHINE OXOACID AMINOTRANSFERASE; PROTEIN HEXOKINASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SOMATOMEDIN BINDING PROTEIN 4; TRANSCRIPTION FACTOR NKX6.1; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

ANAEROBIC GLYCOLYSIS; APOPTOSIS; CELL ACTIVITY; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; DIABETES MELLITUS; GENE REPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; METABOLIC REGULATION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANAEROBIOSIS; ANIMALS; BLOOD GLUCOSE; GENE EXPRESSION REGULATION; GENE SILENCING; GLUCOSE; GLYCOLYSIS; HEXOKINASE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; ORGAN SPECIFICITY;

EID: 84860584838     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1564     Document Type: Review

References (50)

1. Bernard-Kargar C, Ktorza A. Endocrine pancreas plasticity under physiological and pathological conditions. Diabetes 2001;50(Suppl. 1):S30-S35 (Pubitemid 32148212)
2. Quintens R, Hendrickx N, Lemaire K, Schuit F. Why expression of some genes is disallowed in beta-cells. Biochem Soc Trans 2008;36:300-305 (Pubitemid 351839320)
3. Schuit F, Moens K, Heimberg H, Pipeleers D. Cellular origin of hexokinase in pancreatic islets. J Biol Chem 1999;274:32803-32809 (Pubitemid 129535313)
4. Otonkoski T, Jiao H, Kaminen-Ahola N, et al. Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells. Am J Hum Genet 2007;81:467-474 (Pubitemid 47330206)
5. Thorrez L, Laudadio I, Van Deun K, et al. Tissue-specific disallowance of housekeeping genes: the other face of cell differentiation. Genome Res 2011;21:95-105
6. Colsoul B, Schraenen A, Lemaire K, et al. Loss of high-frequency glucose-induced Ca2+ oscillations in pancreatic islets correlates with impaired glucose tolerance in Trpm5-/- mice. Proc Natl Acad Sci USA 2010;107:5208-5213
7. Lemaire K, Moura RF, Granvik M, et al. Ubiquitin fold modifier 1 (UFM1) and its target UFBP1 protect pancreatic beta cells from ER stress-induced apoptosis. PLoS ONE 2011;6:e18517
8. Lemaire K, Ravier MA, Schraenen A, et al. Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice. Proc Natl Acad Sci USA 2009;106:14872-14877
9. Thorrez L, Van Deun K, Tranchevent LC, et al. Using ribosomal protein genes as reference: a tale of caution. PLoS One 2008;3:e1854
10. Van Lommel L, Janssens K, Quintens R, et al. Probe-independent and direct quantification of insulin mRNA and growth hormone mRNA in enriched cell preparations. Diabetes 2006;55:3214-3220 (Pubitemid 44923576)
11. Aguayo-Mazzucato C, Bonner-Weir S. Stem cell therapy for type 1 diabetes mellitus. Nat Rev Endocrinol 2010;6:139-148
12. Jermendy A, Toschi E, Aye T, et al. Rat neonatal beta cells lack the specialised metabolic phenotype of mature beta cells. Diabetologia 2011;54:594-604
13. Schuit F, De Vos A, Farfari S, et al. Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J Biol Chem 1997;272:18572-18579
14. van Arensbergen J, García-Hurtado J, Moran I, et al. Derepression of Polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program. Genome Res 2010;20:722-732
15. Pullen TJ, da Silva Xavier G, Kelsey G, Rutter GA. miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol 2011;31:3182-3194
16. Jonas JC, Sharma A, Hasenkamp W, et al. Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem 1999;274:14112-14121
17. Laybutt DR, Hawkins YC, Lock J, et al. Influence of diabetes on the loss of beta cell differentiation after islet transplantation in rats. Diabetologia 2007;50:2117-2125 (Pubitemid 47373842)
18. Malaisse WJ, Sener A, Herchuelz A, Hutton JC. Insulin release: the fuel hypothesis. Metabolism 1979;28:373-386 (Pubitemid 9144335)
19. Matschinsky FM. Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes 1990;39:647-652 (Pubitemid 20218960)
20. Jensen MV, Joseph JW, Ronnebaum SM, Burgess SC, Sherry AD, Newgard CB. Metabolic cycling in control of glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab 2008;295:E1287-E1297
21. Ivarsson R, Quintens R, Dejonghe S, et al. Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 2005;54:2132-2142 (Pubitemid 40911277)
22. Nolan CJ, Prentki M. The islet beta-cell: fuel responsive and vulnerable. Trends Endocrinol Metab 2008;19:285-291
23. Sekine N, Cirulli V, Regazzi R, et al. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells. Potential role in nutrient sensing. J Biol Chem 1994;269:4895-4902
24. Zhao C, Wilson MC, Schuit F, Halestrap AP, Rutter GA. Expression and distribution of lactate/monocarboxylate transporter isoforms in pancreatic islets and the exocrine pancreas. Diabetes 2001;50:361-366 (Pubitemid 32127293)
25. Ishihara H, Wang H, Drewes LR, Wollheim CB. Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells. J Clin Invest 1999;104:1621-1629 (Pubitemid 30002374)
26. Otonkoski T, Kaminen N, Ustinov J, et al. Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release. Diabetes 2003;52:199-204 (Pubitemid 36042127)
27. Lifson N, Lassa CV, Dixit PK. Relation between blood flow and morphology in islet organ of rat pancreas. Am J Physiol 1985;249:E43-E48 (Pubitemid 15031729)
28. Olsson R, Carlsson PO. A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells. Diabetes 2011;60:2068-2075
29. Schuit FC, In't Veld PA, Pipeleers DG. Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc Natl Acad Sci USA 1988;85:3865-3869
30. Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 1996;20:463-466 (Pubitemid 26077870)
31. Elsner M, Gehrmann W, Lenzen S. Peroxisome-generated hydrogen peroxide as important mediator of lipotoxicity in insulin-producing cells. Diabetes 2011;60:200-208
32. Li X, Chen H, Epstein PN. Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells. Diabetes 2006;55:1592-1604
33. Martens GA, Cai Y, Hinke S, Stangé G, Van de Casteele M, Pipeleers D. Glucose suppresses superoxide generation in metabolically responsive pancreatic beta cells. J Biol Chem 2005;280:20389-20396 (Pubitemid 40776738)
34. Brosnan ME, Brosnan JT. Hepatic glutamate metabolism: a tale of 2 hepatocytes. Am J Clin Nutr 2009;90:857S-861S
35. Ramesh V, McClatchey AI, Ramesh N, et al. Molecular basis of ornithine aminotransferase deficiency in B-6-responsive and -nonresponsive forms of gyrate atrophy. Proc Natl Acad Sci USA 1988;85:3777-3780
36. Montañez-Wiscovich ME, Seachrist DD, Landis MD, Visvader J, Andersen B, Keri RA. LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression. Oncogene 2009;28:3608-3618
37. Liu Z, Habener JF. Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2). Diabetologia 2009;52:1589-1598
38. Liu Z, Stanojevic V, Avadhani S, Yano T, Habener JF. Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival. Diabetologia 2011;54:2067-2076
39. Welsh M, Claesson-Welsh L, Hallberg A, et al. Coexpression of the platelet-derived growth factor (PDGF) B chain and the PDGF beta receptor in isolated pancreatic islet cells stimulates DNA synthesis. Proc Natl Acad Sci USA 1990;87:5807-5811
40. Chen H, Gu X, Liu Y, et al. PDGF signalling controls age-dependent proliferation in pancreatic b-cells. Nature 2011;478:349-355
41. Ning Y, Schuller AG, Conover CA, Pintar JE. Insulin-like growth factor (IGF) binding protein-4 is both a positive and negative regulator of IGF activity in vivo. Mol Endocrinol 2008;22:1213-1225 (Pubitemid 351629620)
42. Cho HJ, Baek KE, Park SM, et al. RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer. Clin Cancer Res 2009;15:2612-2619
43. Veeck J, Chorovicer M, Naami A, et al. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation. Oncogene 2008;27:865-876 (Pubitemid 351186309)
44. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 2004;85:47-64 (Pubitemid 38703594)
45. Lin HM, Lee JH, Yadav H, et al. Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function. J Biol Chem 2009;284:12246-12257
46. De Vos A, Heimberg H, Quartier E, et al. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 1995;96:2489-2495
47. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerström C, Andersson A. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc Natl Acad Sci USA 1994;91:9253-9256 (Pubitemid 24297892)
48. Nishimura W, Bonner-Weir S, Sharma A. Expression of MafA in pancreatic progenitors is detrimental for pancreatic development. Dev Biol 2009;333:108-120
49. Bell SE, Sanchez MJ, Spasic-Boskovic O, et al. The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression. Dev Dyn 2006;235:3144-3155 (Pubitemid 44749704)
50. Hervy M, Hoffman LM, Jensen CC, Smith M, Beckerle MC. The LIM protein zyxin binds CARP-1 and promotes apoptosis. Genes Cancer 2010;1:506-515